Does the media favor STAA or MMSI?

In the previous week, Merit Medical Systems had 14 more articles in the media than STAAR Surgical. MarketBeat recorded 19 mentions for Merit Medical Systems and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat Merit Medical Systems' score of 0.65 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to STAA or ICUI?

In the previous week, STAAR Surgical and STAAR Surgical both had 5 articles in the media. ICU Medical's average media sentiment score of 0.87 beat STAAR Surgical's score of 0.85 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor STAA or HAE?

In the previous week, STAAR Surgical and STAAR Surgical both had 5 articles in the media. STAAR Surgical's average media sentiment score of 0.85 beat Haemonetics' score of 0.28 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer XRAY or STAA?

In the previous week, DENTSPLY SIRONA had 13 more articles in the media than STAAR Surgical. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat DENTSPLY SIRONA's score of 0.10 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is STAA or NEOG more profitable?

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets STAAR Surgical -7.24% 3.31% 2.55% Neogen -69.93% 2.35% 1.46%

Does the media refer more to STAA or NEOG?

In the previous week, STAAR Surgical had 3 more articles in the media than Neogen. MarketBeat recorded 5 mentions for STAAR Surgical and 2 mentions for Neogen. Neogen's average media sentiment score of 0.97 beat STAAR Surgical's score of 0.85 indicating that Neogen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

STAAR Surgical (STAA) Competitors

$29.80 +0.72 (+2.49%)

As of 01:26 PM Eastern

Compare

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

Should you buy STAAR Surgical stock or one of its competitors? MarketBeat compares STAAR Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with STAAR Surgical include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), and Neogen (NEOG). These companies are all part of the "health care supplies" industry.

How does STAAR Surgical compare to Merit Medical Systems?

STAAR Surgical (NASDAQ:STAA) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Merit Medical Systems has a net margin of 9.03% compared to STAAR Surgical's net margin of -7.24%. Merit Medical Systems' return on equity of 13.54% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Merit Medical Systems	9.03%	13.54%	7.94%

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Merit Medical Systems has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	6.20	-$80.45M	-$0.43	N/A
Merit Medical Systems	$1.52B	2.51	$128.49M	$2.31	27.65

In the previous week, Merit Medical Systems had 14 more articles in the media than STAAR Surgical. MarketBeat recorded 19 mentions for Merit Medical Systems and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat Merit Medical Systems' score of 0.65 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

STAAR Surgical presently has a consensus target price of $27.81, suggesting a potential downside of 6.68%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 45.28%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

STAAR Surgical has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Summary

Merit Medical Systems beats STAAR Surgical on 12 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to ICU Medical?

STAAR Surgical (NASDAQ:STAA) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

STAAR Surgical presently has a consensus price target of $27.81, indicating a potential downside of 6.68%. ICU Medical has a consensus price target of $168.00, indicating a potential upside of 22.30%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
ICU Medical	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, STAAR Surgical and STAAR Surgical both had 5 articles in the media. ICU Medical's average media sentiment score of 0.87 beat STAAR Surgical's score of 0.85 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has a net margin of 2.15% compared to STAAR Surgical's net margin of -7.24%. ICU Medical's return on equity of 7.50% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
ICU Medical	2.15%	7.50%	3.91%

STAAR Surgical has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market. Comparatively, ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

ICU Medical has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	6.20	-$80.45M	-$0.43	N/A
ICU Medical	$2.23B	1.54	$730K	$1.85	74.25

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 2.1% of ICU Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

ICU Medical beats STAAR Surgical on 11 of the 15 factors compared between the two stocks.

How does STAAR Surgical compare to Haemonetics?

STAAR Surgical (NASDAQ:STAA) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

STAAR Surgical has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

In the previous week, STAAR Surgical and STAAR Surgical both had 5 articles in the media. STAAR Surgical's average media sentiment score of 0.85 beat Haemonetics' score of 0.28 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Haemonetics has a net margin of 7.29% compared to STAAR Surgical's net margin of -7.24%. Haemonetics' return on equity of 27.30% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Haemonetics	7.29%	27.30%	9.59%

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by insiders. Comparatively, 1.8% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	6.20	-$80.45M	-$0.43	N/A
Haemonetics	$1.33B	2.29	$97.31M	$2.02	33.27

STAAR Surgical currently has a consensus price target of $27.81, indicating a potential downside of 6.68%. Haemonetics has a consensus price target of $77.11, indicating a potential upside of 14.74%. Given Haemonetics' stronger consensus rating and higher probable upside, analysts plainly believe Haemonetics is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
Haemonetics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

Summary

Haemonetics beats STAAR Surgical on 12 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

DENTSPLY SIRONA currently has a consensus price target of $13.82, indicating a potential upside of 31.16%. STAAR Surgical has a consensus price target of $27.81, indicating a potential downside of 6.68%. Given DENTSPLY SIRONA's higher probable upside, equities research analysts clearly believe DENTSPLY SIRONA is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09

STAAR Surgical has a net margin of -7.24% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
STAAR Surgical	-7.24%	3.31%	2.55%

DENTSPLY SIRONA has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

STAAR Surgical has lower revenue, but higher earnings than DENTSPLY SIRONA. STAAR Surgical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$3.15	N/A
STAAR Surgical	$239.44M	6.20	-$80.45M	-$0.43	N/A

In the previous week, DENTSPLY SIRONA had 13 more articles in the media than STAAR Surgical. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat DENTSPLY SIRONA's score of 0.10 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

STAAR Surgical beats DENTSPLY SIRONA on 9 of the 15 factors compared between the two stocks.

How does STAAR Surgical compare to Neogen?

STAAR Surgical (NASDAQ:STAA) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

STAAR Surgical has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market. Comparatively, Neogen has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market.

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Neogen	-69.93%	2.35%	1.46%

STAAR Surgical has higher earnings, but lower revenue than Neogen. STAAR Surgical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	6.20	-$80.45M	-$0.43	N/A
Neogen	$894.66M	2.24	-$1.09B	-$2.80	N/A

In the previous week, STAAR Surgical had 3 more articles in the media than Neogen. MarketBeat recorded 5 mentions for STAAR Surgical and 2 mentions for Neogen. Neogen's average media sentiment score of 0.97 beat STAAR Surgical's score of 0.85 indicating that Neogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neogen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Comparatively, 0.6% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

STAAR Surgical currently has a consensus target price of $27.81, suggesting a potential downside of 6.68%. Neogen has a consensus target price of $10.67, suggesting a potential upside of 15.88%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

STAAR Surgical beats Neogen on 9 of the 16 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.48B	$15.35B	$6.42B	$12.60B
Dividend Yield	N/A	1.28%	2.75%	5.26%
P/E Ratio	-69.35	17.60	21.28	26.32
Price / Sales	6.20	2.27	558.91	114.49
Price / Cash	N/A	13.20	43.49	56.90
Price / Book	4.21	3.14	10.60	7.34
Net Income	-$80.45M	$534.24M	$3.56B	$337.06M
7 Day Performance	-8.21%	3.35%	3.21%	3.67%
1 Month Performance	16.97%	8.90%	6.51%	7.41%
1 Year Performance	62.60%	-1.73%	36.74%	37.93%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	2.1631 of 5 stars	$29.80 +2.5%	$27.81 -6.7%	+60.8%	$1.48B	$239.44M	N/A	1,211	Analyst Forecast
MMSI Merit Medical Systems	4.6848 of 5 stars	$64.17 flat	$92.80 +44.6%	-32.5%	$3.83B	$1.52B	27.78	7,500	Positive News Analyst Revision
ICUI ICU Medical	3.7689 of 5 stars	$133.31 flat	$169.00 +26.8%	+8.1%	$3.33B	$2.23B	72.06	13,000	Analyst Upgrade
HAE Haemonetics	2.7575 of 5 stars	$65.48 0.0%	$77.11 +17.8%	-0.9%	$2.98B	$1.33B	32.42	3,023	Analyst Forecast
XRAY DENTSPLY SIRONA	4.5503 of 5 stars	$10.21 flat	$13.82 +35.3%	-37.7%	$2.05B	$3.68B	N/A	14,000	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Summary

How does STAAR Surgical compare to ICU Medical?

Summary

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Summary

How does STAAR Surgical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Is STAA or MMSI more profitable?

Do insiders and institutionals hold more shares of STAA or MMSI?

Which has higher earnings & valuation, STAA or MMSI?

Does the media favor STAA or MMSI?

Do analysts rate STAA or MMSI?

Which has more risk & volatility, STAA or MMSI?

Summary

How does STAAR Surgical compare to ICU Medical?

Do analysts recommend STAA or ICUI?

Does the media refer more to STAA or ICUI?

Is STAA or ICUI more profitable?

Which has more risk and volatility, STAA or ICUI?

Which has stronger valuation & earnings, STAA or ICUI?

Do insiders and institutionals have more ownership in STAA or ICUI?

Summary

How does STAAR Surgical compare to Haemonetics?

Which has more volatility & risk, STAA or HAE?

Does the media favor STAA or HAE?

Is STAA or HAE more profitable?

Do insiders and institutionals believe in STAA or HAE?

Which has stronger valuation and earnings, STAA or HAE?

Do analysts prefer STAA or HAE?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Do analysts prefer XRAY or STAA?

Is XRAY or STAA more profitable?

Which has more risk and volatility, XRAY or STAA?

Do institutionals & insiders hold more shares of XRAY or STAA?

Which has higher valuation & earnings, XRAY or STAA?

Does the media prefer XRAY or STAA?

Summary

How does STAAR Surgical compare to Neogen?

Which has more risk & volatility, STAA or NEOG?

Is STAA or NEOG more profitable?

Which has preferable earnings and valuation, STAA or NEOG?

Does the media refer more to STAA or NEOG?

Do insiders & institutionals have more ownership in STAA or NEOG?

Do analysts recommend STAA or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools